PH22631A - Pyridazino(4,3-a)isoquinoline derivatives - Google Patents
Pyridazino(4,3-a)isoquinoline derivativesInfo
- Publication number
- PH22631A PH22631A PH30962A PH30962A PH22631A PH 22631 A PH22631 A PH 22631A PH 30962 A PH30962 A PH 30962A PH 30962 A PH30962 A PH 30962A PH 22631 A PH22631 A PH 22631A
- Authority
- PH
- Philippines
- Prior art keywords
- pyridazino
- isoquinoline derivatives
- amino
- phenyl
- groups
- Prior art date
Links
- 125000002183 isoquinolinyl group Chemical class C1(=NC=CC2=CC=CC=C12)* 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000000049 anti-anxiety effect Effects 0.000 abstract 1
- 239000002249 anxiolytic agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000000 cycloalkoxy group Chemical group 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- AFCCQNLWUCZFJN-UHFFFAOYSA-N pyridazino[4,3-c]isoquinoline Chemical class C1=NN=C2C3=CC=CC=C3C=NC2=C1 AFCCQNLWUCZFJN-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Anesthesiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT22013/83A IT1194309B (it) | 1983-07-12 | 1983-07-12 | Derivati 3-fenil-piridazino (4,3-c) isochinolinici |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH22631A true PH22631A (en) | 1988-10-28 |
Family
ID=11190189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH30962A PH22631A (en) | 1983-07-12 | 1984-07-11 | Pyridazino(4,3-a)isoquinoline derivatives |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4716159A (OSRAM) |
| EP (1) | EP0134461B1 (OSRAM) |
| JP (1) | JPS6048989A (OSRAM) |
| KR (1) | KR910005849B1 (OSRAM) |
| AT (1) | ATE30157T1 (OSRAM) |
| AU (1) | AU570057B2 (OSRAM) |
| CA (1) | CA1229602A (OSRAM) |
| DE (1) | DE3466690D1 (OSRAM) |
| DK (1) | DK323484A (OSRAM) |
| ES (1) | ES534200A0 (OSRAM) |
| FI (1) | FI77861C (OSRAM) |
| GR (1) | GR82126B (OSRAM) |
| HU (1) | HU193687B (OSRAM) |
| IL (1) | IL72308A (OSRAM) |
| IT (1) | IT1194309B (OSRAM) |
| NO (1) | NO160613C (OSRAM) |
| NZ (1) | NZ208864A (OSRAM) |
| PH (1) | PH22631A (OSRAM) |
| PT (1) | PT78891B (OSRAM) |
| ZA (1) | ZA844970B (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0633277B2 (ja) * | 1986-01-10 | 1994-05-02 | 吉富製薬株式会社 | ベンゾチオピラノ〔４，３−ｃ〕ピリダジン化合物 |
| DE3814552A1 (de) * | 1988-04-29 | 1989-11-09 | Hoechst Ag | 9-oxo-1,9a-10-triaza-9-hydro-anthracen- verbindungen, verfahren zu ihrer herstellung und ihre verwendung als farbmittel |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4062958A (en) * | 1976-09-22 | 1977-12-13 | American Cyanamid Company | Method of treating anxiety and compositions therefor |
-
1983
- 1983-07-12 IT IT22013/83A patent/IT1194309B/it active
-
1984
- 1984-06-26 GR GR75128A patent/GR82126B/el unknown
- 1984-06-27 FI FI842586A patent/FI77861C/fi not_active IP Right Cessation
- 1984-06-29 DE DE8484107554T patent/DE3466690D1/de not_active Expired
- 1984-06-29 AT AT84107554T patent/ATE30157T1/de not_active IP Right Cessation
- 1984-06-29 EP EP84107554A patent/EP0134461B1/en not_active Expired
- 1984-06-29 ZA ZA844970A patent/ZA844970B/xx unknown
- 1984-06-29 DK DK323484A patent/DK323484A/da not_active Application Discontinuation
- 1984-07-03 AU AU30221/84A patent/AU570057B2/en not_active Ceased
- 1984-07-05 IL IL72308A patent/IL72308A/xx unknown
- 1984-07-10 JP JP59141572A patent/JPS6048989A/ja active Granted
- 1984-07-11 PH PH30962A patent/PH22631A/en unknown
- 1984-07-11 HU HU842715A patent/HU193687B/hu unknown
- 1984-07-11 KR KR1019840004038A patent/KR910005849B1/ko not_active Expired
- 1984-07-11 PT PT78891A patent/PT78891B/pt not_active IP Right Cessation
- 1984-07-11 NZ NZ208864A patent/NZ208864A/xx unknown
- 1984-07-11 ES ES534200A patent/ES534200A0/es active Granted
- 1984-07-11 NO NO842825A patent/NO160613C/no unknown
- 1984-07-11 CA CA000458578A patent/CA1229602A/en not_active Expired
-
1986
- 1986-07-30 US US06/891,815 patent/US4716159A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0559915B2 (OSRAM) | 1993-09-01 |
| PT78891B (en) | 1986-10-23 |
| ATE30157T1 (de) | 1987-10-15 |
| ES8600289A1 (es) | 1985-06-01 |
| JPS6048989A (ja) | 1985-03-16 |
| NO160613C (no) | 1989-05-10 |
| ES534200A0 (es) | 1985-06-01 |
| FI842586A7 (fi) | 1985-01-13 |
| PT78891A (en) | 1984-08-01 |
| GR82126B (OSRAM) | 1984-12-13 |
| DE3466690D1 (de) | 1987-11-12 |
| NO160613B (no) | 1989-01-30 |
| ZA844970B (en) | 1985-03-27 |
| AU3022184A (en) | 1985-01-17 |
| IL72308A (en) | 1987-11-30 |
| FI842586A0 (fi) | 1984-06-27 |
| FI77861C (fi) | 1989-05-10 |
| FI77861B (fi) | 1989-01-31 |
| DK323484A (da) | 1985-01-13 |
| CA1229602A (en) | 1987-11-24 |
| NZ208864A (en) | 1988-06-30 |
| IT1194309B (it) | 1988-09-14 |
| HU193687B (en) | 1987-11-30 |
| US4716159A (en) | 1987-12-29 |
| KR850001209A (ko) | 1985-03-16 |
| KR910005849B1 (ko) | 1991-08-05 |
| IT8322013A0 (it) | 1983-07-12 |
| DK323484D0 (da) | 1984-06-29 |
| EP0134461A1 (en) | 1985-03-20 |
| AU570057B2 (en) | 1988-03-03 |
| HUT34975A (en) | 1985-05-28 |
| EP0134461B1 (en) | 1987-10-07 |
| IL72308A0 (en) | 1984-11-30 |
| NO842825L (no) | 1985-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3262698D1 (en) | Antifibrinolytically active compounds | |
| SE8201854L (sv) | N-substituerade amino-aminosyror | |
| AU560726B2 (en) | Triazolo(3,4-a)phthalazine and their use as anti-anxiety agents | |
| PH22631A (en) | Pyridazino(4,3-a)isoquinoline derivatives | |
| DE3477782D1 (en) | Imidazo(1,2-c)pyrimidines and their salts, process for their preparation, their use as medicaments and compositions containing them | |
| ES8505682A1 (es) | Metodo para preparar derivados de acidos b-carbolin-3-barboxilicos | |
| ES8200113A1 (es) | Un procedimiento para la preparacion de derivados de cefalosporina. | |
| IL72529A (en) | (hetero)aryl-(1,2,4)triazolo(1,5-c)pyrimidin-2-amines and antianaphylactic pharmaceutical compositions containing them | |
| GR81771B (OSRAM) | ||
| DE3160719D1 (en) | Benzothiopyrano(2,3-c) pyridines and their acid addition salts, their preparation, their use as medicaments and compositions containing them |